ISU, a trailblazer in consumer engagement and brand strategy, has successfully raised $3,000,000 in its latest funding round, a significant step forward in its mission to revolutionize the way brands connect with their audiences. Specializing in the development of conceptual strategies, ISU is dedicated to understanding consumer desires — what they want, how they want it, and when. This funding will enable the company to enhance its innovative approaches to creating impactful brands that leave a lasting impression on consumers' minds. With a keen focus on personalized testing, ISU is committed to building synergy between businesses and their internal customers, aligning perfectly with market demands and preferences. The investment will be utilized to expand ISU's capabilities in research and development, allowing for the creation of advanced consumer insights tools that will further refine brand positioning strategies. As the company strives to scale its operations, this financial boost also aims to foster talent acquisition, enhancing ISU's creative and strategic teams. Ultimately, the funding will not only empower ISU to amplify its unique methodologies but also ensure that brands can cultivate deeper connections with their consumers, leading to sustained growth and loyalty in an ever-evolving marketplace. This announcement marks a significant milestone for ISU as it sets the stage for greater innovation and impactful brand positioning in a world where consumer preferences continuously evolve.

ISU Secures $3 Million in Funding for Innovative Consumer Connection Strategies Company
Get the full ISU company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Raptor Scientific
Leading Technology for Mission Critical Applications Raptor Scientific offers an extensive range of test and measurement capabilities, including Mass Properties, Radar Cross Section Measurement Instruments, Air Data Test Systems, Pressure, Temperature, Torque & Force Measurement Instruments, Igniter Circuit Testers, Heat Flux Sensors, Infrared Radiometers, and Thermocouples for developers of high-performance systems for whom failure is not an option. Our groundbreaking solutions offer the highest level of accuracy, safety, and exceptional product reliability.
$100.0K Unknown
today

Quantifly
Quantifly (TM) changes how parking and traffic studies are done. No more weeks of planning, RFPs, and hiring interns. Just select the type, duration, and location of your study, if you need a drone pilot or need us to provide one, then we do the rest. In about a week you get the photos, video, and car count data created automatically with our proprietary algorithm, and requested reports. No more counting cars in the snow. Parking and traffic counts are essential to urban development. Without them municipalities and developers have few options to calculate parking or street capacity. These studies are costly, time consuming, and consist of people manually counting cars on foot in all seasons using pen and paper, increasing the possibility for human error. The analog data from these studies are transcribed to a proprietary database and often left siloed. We save our clients time and money, minimize human error, and use visual data to increase the quality of communication with elected officials and the general public. As we get more data, we give planners and developers tools to dictate how and where parking happens. Quantifly is a joint venture wholly owned and operated by Autonomous Scientific and Pivot Planning & Design.
$600.0K Seed
today

Pulmonx Corporation
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1 Complications of the Zephyr Endobronchial Valve treatment can include but are not limited to pneumothorax, worsening of COPD symptoms, hemoptysis, pneumonia, dyspnea and, in rare cases, death.1 1. Criner G et al AM J Resp Crit Care Med 2018, Published on 22-May-2018 as 10.1164/rccm.201803-0590OC Brief Statement: The Pulmonx Zephyr® Endobronchial Valves are implantable bronchial valves indicated for the bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. The Zephyr Valve is contraindicated for: Patients for whom bronchoscopic procedures are contraindicated; those with evidence of active pulmonary infection; known allergies to Nitinol (nickel-titanium) or its constituent metals (nickel or titanium); known allergies to silicone, or with large bullae encompassing greater than 30% of either lung; Patients who have not quit smoking. The Zephyr Valve should be used with caution and only after careful consideration in treating patients with: Prior lung transplant, LVRS, median sternotomy, or lobectomy; Congestive heart failure or recent myocardial infarction; FEV1 <15% of predicted value. Use is restricted to a trained physician. Prior to use, please reference the Zephyr Endobronchial Valve System Instructions for more information on indications, contraindications, warnings, all precautions, and adverse events.
$66.0M Series d
today

Penteo Audio Plugins
Since 2012, Penteo’s unique phaseless AAX / VST3 / AU audio plugins produce the highest quality multichannel upmix/downmix that always adheres to the original mixers intent: nothing is artificially added, altered or removed from the source in Penteo's upmix / downmix process. Free 14-day trial: www.perfectsurround.com/freetrial
$100.0K Unknown
today

Oculyze
Using machine learning and Artificial Intelligence Oculyze has transferred the computer vision software for lab equipment from the table top to the cloud. To prove this revolutionary approach works and is market ready, Oculyze launched the yeast cell counters for breweries and wineries. This device works using a microscope connected to a smartphone and the Oculyze app to upload the images to the cloud where they are analysed by image recognition algorithms. These combine methodical pattern recognition with artificial intelligence and deep learning to offer quantitative real-time image analysis. The cell counter has convinced yeast labs, breweries and wineries of all sizes around the world (Oculyze Better Brewing + Fermentation Wine). Oculyze MUH is the third turnkey product and allows for an on-site diagnosis of subclinical endometritis for cows. The next step for Oculyze is to use this proven technology to bring the advantages of cloud based image recognition, like faster development time, lower cost and better image recognition, to other applications like blood or sperm counts, parasite detection in feces, asbestos fibre detection, emulsion analysis and bacteria detection, hereby continuing to add applications to its cloud based image recognition platform. The beauty of this solution is that it can be delivered in two ways: One is a brand new system developed specifically for an application, and the second is the combination of APIs and Apps that enable the company to upgrade existing hardware like scanning electron microscopes (SEM) or the good old lab microscope.
$100.0K Seed
today